Strong Economic Growth Draws Pharma Companies to Malaysia

by

A rapidly growing pharma market and environment friendly to clinical trials are among the features that are attracting a growing number of multinational pharmaceutical companies to Malaysia. However, those pluses are balanced by decided favoritism toward domestic production, seen in government supply contracts and tax codes. According to a September 2016 report by PharmSource’s colleagues […]

Learn more

NDA Outsourcing Up, Despite NME Decline

by

In 2016, outsourced dose form manufacturing of NDA approvals reached 60%, some 10% higher than the five-year average. This and other insights into CMO performance were revealed in PharmSource’s recently published CMO Scorecard. In what proved to be a mediocre year for drug approvals, the increase in outsourcing levels was restricted to the manufacture of […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on BioCryst Pharmaceuticals, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. BioCryst Pharmaceuticals is a U.S. public bio/pharmaceutical company that discovers drugs for the treatment of infectious diseases, inflammatory diseases and cancer. It plans to raise […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on RenalGuard Solutions, Inc.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. RenalGuard Solutions, Inc. is a U.S. private company that develops cardiac and vascular technologies. It raised $14.5 million in […]

Learn more

PharmSource Coverage of AACR 2017 Yields Valuable BD Info

by

You might have noticed it was a busy week on the PharmSource Lead Sheet. The beginning of April found myself and fellow Research Analyst, Mahdia Hashimy, covering the 2017 American Association for Cancer Research (AACR) conference in Washington DC. Here we gathered all the latest news and early research data in the oncology field from […]

Learn more

Look out! Zika!

by

The Zika virus has become a global concern since its epidemic in 2015-2016. During that time, on February 26, 2016, Sylvia Burwell of the US Health and Human Services declared the authorization of emergency use of in vitro diagnostics for the detection and diagnosis of the Zika virus.1 According to the PharmSource Lead Sheet: Device […]

Learn more

Bio/Pharmaceutical Outsourcing Report – Special DCAT 2017 Edition

by

PharmSource has published a special DCAT Edition of our proprietary industry briefing, Bio/Pharmaceutical Outsourcing Report. This monthly report reports on and analyzes major developments throughout the CMO industry. It provides expert insight into the significance of industry trends and what they mean for your business. Deepen your understanding of what’s happening in commercial and clinical […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Aldeyra Therapeutics, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Aldeyra Therapeutics is a U.S. public bio/pharmaceutical company that develops potent, small molecule, irreversible aldehyde traps for the treatment of diseases caused by inflammation and […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on Flow Forward Medical, LLC

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Flow Forward Medical is a U.S. private company that develops cardiovascular devices to improve eligibility and reduce maturation failure […]

Learn more

Time to Hit the Road!

by

The pharma trade show season is officially in full swing! Whether your organization is a CRO, CMO, CDMO or any other service provider to the pharma/biotech/device and diagnostics industry, chances are you’ve either recently attended, or will be attending, an industry event over the next few months. If this is the case, make sure you’re […]

Learn more